Table 3.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Costs (per × 103 JPY/day increase) | 1.04 | 1.03–1.05 | < 0.001* | 1.03 | 1.02–1.04 | < 0.001* |
Emergent initiation (vs. planned) | 16.39 | 4.9–102.0 | < 0.001* | 7.00 | 1.78–46.60 | 0.004* |
CRP (per 0.1 mg/dL increase) | 1.02 | 1.02–1.03 | < 0.001* | 1.01 | 1.00–1.02 | 0.01* |
BP < 130 mmHg (vs. ≥ 130) | 3.57 | 1.46–7.95 | 0.007* | 2.77 | 0.91–7.54 | 0.07 |
Age ≥ 80 years old (vs. < 80) | 4.91 | 2.23–10.65 | < 0.001* | 2.13 | 0.82–5.48 | 0.12 |
CVD (vs. without CVD) | 4.05 | 1.72–11.09 | 0.001* | 1.63 | 0.50–5.83 | 0.42 |
Female (vs. male) | 1.28 | 0.54–2.80 | 0.56 | 1.43 | 0.56–3.53 | 0.44 |
DM (vs. without DM) | 0.86 | 0.37–1.90 | 0.72 | 0.87 | 0.30–2.47 | 0.80 |
AKI (vs. without AKI) | 6.02 | 2.63–13.15 | < 0.001* | 1.04 | 0.31–3.00 | 0.95 |
HR hazard ratio, CI confidence interval, BP blood pressure, CVD cardiovascular disease, DM diabetes mellitus, AKI acute kidney injury, JPY Japanese Yen.
*p value < 0.05.